Has Margaret Mann, MD received payments from drug or device companies?

Yes. Drug and device makers reported $16,379 in general payments to Margaret Mann, MD across 374 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Margaret Mann, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Margaret Mann, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Margaret Mann, MD

MOHS-Micrographic Surgery · Hendersonville, TNNPI 1992717490

Payments from drug & device makers

$16,379in general payments, 2019–2025

Across 374 payments — averaging $43.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Galderma Laboratories, L.p.$5K
Merz North America, Inc.$4K
AbbVie$1K
Johnson & Johnson$1K
Sun Pharmaceutical Industries Inc.$650
Regeneron Healthcare Solutions, Inc.$431
plus $4K from 38 others

What the payments were for

Consulting fees$3,81023%
Grants$4,80029%
Food & beverage$7,19744%
Education$5723%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Galderma Laboratories, L.p.	9	$4,935
Merz North America, Inc.	5	$3,765
AbbVie(2 entities)	82	$1,464
Johnson & Johnson(2 entities)	64	$1,411
Sun Pharmaceutical Industries Inc.	32	$650
Regeneron Healthcare Solutions, Inc.	19	$431
Novartis	16	$374
Sanofi	13	$339
Pfizer	17	$301
Biofrontera Inc.	12	$246
Convatec Inc.	6	$219
E.r. Squibb & Sons, L.L.C.	7	$198
Amgen	10	$196
Lilly USA, LLC	11	$192
Organon	8	$185
Vector Surgical, LLC	1	$150
Genentech USA, Inc.	8	$146
Lumenis BE Inc	1	$144
Incyte Corporation	5	$106
Dermavant Sciences, Inc.	4	$100
UCB, Inc.	3	$74
Medtronic	5	$71
LEO Pharma Inc.	4	$66
Strata Skin Sciences, Inc.	6	$66
Octapharma USA, Inc.	1	$65
Journey Medical Corporation	4	$62
Almirall LLC	2	$49
Bristol Myers Squibb	2	$45
Verrica Pharmaceuticals Inc.	2	$42
Boston Scientific	1	$27
Botanix SB Inc	1	$24
EPI Health, LLC	1	$24
Sandoz	1	$24
Arcutis Biotherapeutics, Inc.	1	$22
Baxter Healthcare	1	$21
Organogenesis Inc.	1	$20
Fresenius Kabi USA, LLC	1	$20
DUSA Pharmaceuticals, Inc.	1	$17
Dermira, Inc.	1	$17
Teva Pharmaceuticals USA, Inc.	1	$17
Angiodynamics, Inc.	1	$15
Solta Medical, A Division Of Bausch Health US, LLC	1	$15
Mimedx Group, Inc.	1	$13
Helsinn Therapeutics (U.S.), Inc.	1	$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$16,379 in reported general payments places this provider in the 85th percentile of 40 mohs-micrographic surgery providers in Tennessee.

See all mohs-micrographic surgery providers in Tennessee →

Medicare billing

Part B allowed, 2024

$544,309

Medicare patients

360

Services billed

2,937

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Clobetasol Propionate	42	$1,924
Doxycycline Hyclate	59	$856
Triamcinolone Acetonide	70	$816
Ketoconazole	32	$578
Mupirocin	49	$416
ValacyclovirValacyclovir Hcl	26	$368
Finasteride	11	$135
Terbinafine Hcl	11	$54

Paid to pharmacies, not to this prescriber.

Other mohs-micrographic surgery in Hendersonville

William TidwellHendersonville$7K
Stephen D' AddarioHendersonville$945
Dafnis CarranzaHumboldt$1M
Brent MoodyNashville$1M
Vineet MishraNashville$44K
Joseph ProhaskaMorristown$21K
Megan MorrisonThompsons Station$10K
Michael PelsterNashville$10K
Courtney WoodmanseeMemphis$9K
Matthew HanggiKnoxville$9K

See the full list for Tennessee →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →